• ქართული
  • English
  • Takeda shareholders give nod for $59 billion Shire acquisition

    Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.

    Market Quotes by TradingView